Enzymatic method for producing l-glufosinate and its phosphoesters
US-2024117327-A1 · Apr 11, 2024 · US
US9540700B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9540700-B2 |
| Application number | US-201414455747-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2014 |
| Priority date | May 12, 2006 |
| Publication date | Jan 10, 2017 |
| Grant date | Jan 10, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods and compositions for identifying transgenic seed that contain a transgene of interest, but lack a marker gene. Use of an identification sequence that results in a detectable phenotype increases the efficiency of screening for seed and plants in which transgene sequences not linked to a gene of interest have segregated from the sequence encoding a gene of interest.
Opening claim text (preview).
What is claimed is: 1. A method of preparing marker-free seeds from a transgenic plant, comprising the steps of: a) obtaining seeds from a transgenic plant, said plant comprising: a first DNA segment comprising a nucleic acid of interest, and a second DNA segment comprising a marker gene physically linked to a DNA cassette that is operably linked to a promoter functional in said seed, wherein the DNA cassette confers a detectable phenotype selected from the group consisting of: change in seed color, change in seed texture, change in seed shape, and change in seed opacity; b) screening the seeds for the absence of the detectable phenotype; and c) selecting at least a first seed that lacks the detectable phenotype, to obtain a seed free of the marker gene; wherein said detectable phenotype is not conferred by gus or gfp. 2. The method of claim 1 , wherein step c) further comprises assaying the seed for the presence of the nucleic acid of interest and selecting a seed that comprises the nucleic acid of interest. 3. The method of claim 1 , wherein the marker gene is a selectable marker gene. 4. The method of claim 3 , wherein the DNA cassette encodes an RNA that is translationally or transcriptionally fused to the selectable marker gene. 5. The method of claim 1 , wherein the first DNA segment and second DNA segment overlap. 6. The method of claim 1 , wherein the seed selected in step c) lacks the marker gene and DNA cassette. 7. The method of claim 1 , wherein the transgenic plant or a progenitor thereof of any previous generation was co-transformed with the first and second DNA segments on separate DNA constructs. 8. The method of claim 1 , wherein the first and second DNA segments are bounded by different T-DNA border sequences. 9. The method of claim 8 , wherein step a) comprises transforming the transgenic plant or a progenitor thereof of any previous generation with a single DNA construct comprising the first and second DNA segments. 10. The method of claim 1 , wherein the transgenic plant was produced by transforming the plant or a progenitor thereof of any previous generation with a DNA construct comprising (i) the first DNA segment flanked by left and right T-DNA borders comprising a nucleic acid of interest, and (ii) the second DNA segment flanked by a second set of left and right T-DNA borders, wherein the second DNA segment further comprises a marker gene operably linked to a promoter functional in the transgenic plant. 11. The method of claim 1 , wherein the first and second DNA segments are not genetically linked in said transgenic plant. 12. The method of claim 1 , wherein the first and second DNA segments are genetically linked in said transgenic plant. 13. The method of claim 1 , wherein the transgenic plant was produced by introducing the first and second DNA segments into said plant or a progenitor thereof of any previous generation by transformation mediated by a bacterial strain selected from the genus consisting of Agrobacterium, Rhizobium, Mesorhizobium , and Sinorhizobium. 14. The method of claim 3 , wherein the selectable marker gene encodes a product selected from the group consisting of CP4 EPSPS, phosphinothricin acetyltransferase, DMO, NptII, glyphosate acetyl transferase, mutant acetolactate synthase, methotrexate resistant DHFR, dalapon dehalogenase, PMI, Protox, hygromycin phosphotransferase and 5-methyl tryptophan resistant anthranilate synthase. 15. The method of claim 1 , wherein the DNA cassette comprises a sequence selected from the group consisting of crtB, an anthocyanin synthesis gene, cobA, and B-peru. 16. The method of claim 1 , wherein the DNA cassette is operably linked to a promoter functional in a tissue selected from an embryo, seed endosperm, cotyledon, aleurone, and seed coat. 17. The method of claim 1 , wherein the DNA cassette comprises a nucleic acid sequence operably linked to a promoter selected from the group consisting of a napin promoter, a beta-phaseolin promoter, a beta-conglycinin subunit promoter, a zein promoter, an Osgt-1 promoter, an oleosin promoter, a starch synthase promoter, a globulin 1 promoter, a barley LTP2 promoter, an alpha-amylase promoter, a chitinase promoter, a beta-glucanase promoter, a cysteine proteinase promoter, a glutaredoxin promoter, a HVA1 promoter, a serine carboxypeptidase II promoter, a catalase promoter, an alpha-glucosidase promoter, a beta-amylase promoter, a VP1 promoter, a USP promoter, a USP88 promoter, a USP99 promoter, a Lectin promoter, and a bronze2 promoter. 18. The method of claim 1 , wherein the detectable phenotype is assayed by detection of a catalytic activity. 19. The method of claim 1 , wherein step c) is carried out by an automated seed sorting machine. 20. A DNA construct comprising: (a) a first DNA segment comprising left and right T-DNA borders flanking: a gene of interest operably linked to a promoter functional in plants, and (b) a second DNA segment comprising a second set of left and right T-DNA borders flanking: a promoter functional in a seed operably linked to a DNA cassette that confers a detectable phenotype in seeds that comprise the DNA cassette, and a marker gene operably linked to a promoter functional in plants; wherein the detectable phenotype is selected from the group consisting of: change in seed color, change in seed texture, change in seed shape, and change in seed opacity; and wherein said detectable phenotype is not conferred by gus or gfp. 21. The DNA construct of claim 20 , wherein the marker gene is a selectable marker gene. 22. The construct of claim 20 , wherein the gene of interest confers a trait selected from the group consisting of herbicide tolerance, insect or pest resistance, disease resistance, increased biomass, modified fatty acid metabolism, modified carbohydrate metabolism, and modified nutritional quality. 23. The construct of claim 20 , wherein the DNA cassette and selectable marker gene are operably linked to the same promoter. 24. The construct of claim 20 , wherein the DNA cassette and the selectable marker gene are operably linked to different promoters. 25. The construct of claim 20 , wherein the selectable marker gene encodes a product selected from the group consisting of CP4 EPSPS, phosphinothricin acetyltransferase, DMO, NptII, glyphosate acetyl transferase, mutant acetolactate synthase, methotrexate resistant DHFR, dalapon dehalogenase, PMI, Protox, hygromycin phosphotransferase and 5-methyl tryptophan resistant anthranilate synthase. 26. The construct of claim 20 , wherein the DNA cassette comprises a sequence selected from the group consisting of crtB, an anthocyanin synthesis gene, cobA, and B-peru. 27. The construct of claim 20 , wherein the DNA cassette is operably linked to a promoter functional in a tissue selected from the group consisting of an embryo, seed endosperm, cotyledon, aleurone, and seed coat. 28. The construct of claim 20 , wherein the DNA cassette is operably linked to a promoter selected from the group consisting of a napin promoter, a beta-phaseolin promoter, a beta-conglycinin subunit promoter, a zein promoter, an Osgt-1 promoter, an oleosin promoter, a starch synthase promoter, a globulin 1 promoter, a barley LTP2 promoter, an alpha-amylase promoter, a chitinase promoter, a beta-glucanase promoter, a cysteine proteinase promoter, a glutaredoxin promoter, a HVA1 promoter, a s
Colour markers, e.g. beta-glucoronidase [GUS], green fluorescent protein [GFP], carotenoid · CPC title
Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers · CPC title
Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers · CPC title
Agrobacterium mediated transformation · CPC title
for fertility modification, e.g. apomixis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.